<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00486148</url>
  </required_header>
  <id_info>
    <org_study_id>PLA-1-GOS-05</org_study_id>
    <nct_id>NCT00486148</nct_id>
  </id_info>
  <brief_title>Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS)</brief_title>
  <official_title>Randomized, Double Blind Study to Evaluate the Safety and Efficacy of an Infant Formula Supplemented With Galacto-oligosaccharides (GOS) in Healthy, Full Term Infants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Heinz Italia SpA</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Heinz Italia SpA</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to determine the safety and efficacy of an infant formula
      supplemented with a &quot;prebiotic&quot; component (GOS) in improving the gut microflora balance,
      mimicking that of breast-fed infants.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Oligosaccharides are one of the major breast milk components. They are not digested and reach
      the colon where they're used by selected groups of microflora positive bacteria, specifically
      bifidobacteria and lactobacilli.

      Therefore, oligosaccharides have prebiotic effects accountable for health benefits in
      infants.

      Over the last years the supplementation of infant formulae has been studied to mimic breast
      milk prebiotic functions enhancing gut microflora growth similar to that of breast fed
      infants.

      However further scientific data are necessary to support the efficacy of the supplementation
      of oligosaccharide in infant formulae.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date type="Actual">June 2013</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The nutritional safety through anthropometric controls. Adverse events: diarrhea, crying, gaseous colics, regurgitation, vomit, skin rashes, fever.</measure>
    <time_frame>Anthropometric controls at birth, on enrolment, after 1, 2, 3, 4 months of life and just before starting weaning. Adverse events daily.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>The prebiotic effect through the control of the feces consistency and frequency, the incidence of gaseous colics and microbiological analyses of the fecal samples.</measure>
    <time_frame>Feces consistency and frequency, and incidence of gaseous colics, microbiological analyses of the fecal samples on enrolment and after 1 and 2 months of life.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">360</enrollment>
  <condition>Nutritional Safety</condition>
  <arm_group>
    <arm_group_label>group &quot;S&quot;</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Breast milk</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group &quot;A&quot;</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Control Infant formula</description>
  </arm_group>
  <arm_group>
    <arm_group_label>group &quot;B&quot;</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Infant formula supplemented with 0.4 g/100 ml of oligosaccharides</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Infant formula (with GOS)</intervention_name>
    <description>Infant formula supplemented with 0.4 g/100 ml of galacto-oligosaccharides</description>
    <arm_group_label>group &quot;B&quot;</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Healthy infants of both sexes, born at term with natural labor or cesarean birth

          2. Single birth

          3. Infant born between 37th - 42th gestation week (included)

          4. Infant with birth weight ≥ 2500 g

          5. APGAR score after 5 minutes of life &gt; 7

          6. Infant born from parents of Caucasian race

          7. Exclusive breast feeding or formula feeding within 15 days from birth.

          8. Consensus form signed by both parents or by the legal tutor properly informed of the
             study.

          9. Parents able to understand the protocol requirements and to fill out the infants
             Diary.

        Exclusion Criteria:

          1. Infant with inborn malformation and with hereditary and/or chronic and/or inborn
             diseases requiring hospital care superior to 7 days.

          2. Diseases jeopardizing intrauterine growth.

          3. Infant born from mother suffering from dismetabolic and/or chronic diseases.

          4. Unknown father

          5. Infant with parents who might not report at hospital controls or not follow the
             protocol.

          6. Infant already enrolled or selected for another clinical trial.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>15 Days</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Carlo Agostoni, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera San Paolo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Gian Vincenzo Zuccotti, Prof</last_name>
    <role>Principal Investigator</role>
    <affiliation>Azienda Ospedaliera &quot;Luigi Sacco&quot;</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Giacomo Biasucci, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale Civile &quot;G. da Saliceto&quot;</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Fabio Alberto Podestà, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale San Carlo Borromeo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Amilcare Rottoli, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>&quot;Casa Pia Ospitaliera Uboldo&quot; - Ospedale &quot;Santa Maria delle Stelle&quot;</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Cino Galluzzo, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ospedale &quot;Sacra Famiglia del Fatebenefratelli&quot;</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>&quot;Casa Pia Ospitaliera Uboldo&quot; Unità Operativa di Pediatria e Neonatologia</name>
      <address>
        <city>Cernusco sul Naviglio (Milan)</city>
        <zip>20063</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;Sacra Famiglia del Fatebenefratelli&quot; Unità Operativa di Pediatria e Neonatologia</name>
      <address>
        <city>Erba (Como)</city>
        <zip>22036</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;Santa Maria delle Stelle&quot; Unità Operativa di Pediatria e Neonatologia</name>
      <address>
        <city>Melzo (MI)</city>
        <zip>20066</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda ospedaliera &quot;San Paolo&quot;, Dipartimento di Pediatria</name>
      <address>
        <city>Milan</city>
        <zip>20142</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale &quot;San Carlo Borromeo&quot; Unità Operativa di Pediatria</name>
      <address>
        <city>Milan</city>
        <zip>20152</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Azienda Ospedaliera &quot;Luigi Sacco&quot; Unità Operativa di Pediatria</name>
      <address>
        <city>Milan</city>
        <zip>20157</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Ospedale Civile &quot;G. da Saliceto&quot; Unità Operativa di Pediatria</name>
      <address>
        <city>Piacenza</city>
        <zip>29100</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Mountzouris KC, McCartney AL, Gibson GR. Intestinal microflora of human infants and current trends for its nutritional modulation. Br J Nutr. 2002 May;87(5):405-20. Review.</citation>
    <PMID>12010580</PMID>
  </reference>
  <reference>
    <citation>Agostoni C, Axelsson I, Goulet O, Koletzko B, Michaelsen KF, Puntis JW, Rigo J, Shamir R, Szajewska H, Turck D; ESPGHAN Committee on Nutrition. Prebiotic oligosaccharides in dietetic products for infants: a commentary by the ESPGHAN Committee on Nutrition. J Pediatr Gastroenterol Nutr. 2004 Nov;39(5):465-73.</citation>
    <PMID>15572882</PMID>
  </reference>
  <reference>
    <citation>Gibson GR, Roberfroid MB. Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. J Nutr. 1995 Jun;125(6):1401-12. Review.</citation>
    <PMID>7782892</PMID>
  </reference>
  <reference>
    <citation>Macfarlane GT, Cummings JH. Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health? BMJ. 1999 Apr 10;318(7189):999-1003. Review.</citation>
    <PMID>10195977</PMID>
  </reference>
  <reference>
    <citation>Moro G, Minoli I, Mosca M, Fanaro S, Jelinek J, Stahl B, Boehm G. Dosage-related bifidogenic effects of galacto- and fructooligosaccharides in formula-fed term infants. J Pediatr Gastroenterol Nutr. 2002 Mar;34(3):291-5.</citation>
    <PMID>11964956</PMID>
  </reference>
  <reference>
    <citation>Boehm G, Lidestri M, Casetta P, Jelinek J, Negretti F, Stahl B, Marini A. Supplementation of a bovine milk formula with an oligosaccharide mixture increases counts of faecal bifidobacteria in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2002 May;86(3):F178-81.</citation>
    <PMID>11978748</PMID>
  </reference>
  <reference>
    <citation>Schmelzle H, Wirth S, Skopnik H, Radke M, Knol J, Böckler HM, Brönstrup A, Wells J, Fusch C. Randomized double-blind study of the nutritional efficacy and bifidogenicity of a new infant formula containing partially hydrolyzed protein, a high beta-palmitic acid level, and nondigestible oligosaccharides. J Pediatr Gastroenterol Nutr. 2003 Mar;36(3):343-51.</citation>
    <PMID>12604972</PMID>
  </reference>
  <reference>
    <citation>Long SS, Swenson RM. Development of anaerobic fecal flora in healthy newborn infants. J Pediatr. 1977 Aug;91(2):298-301.</citation>
    <PMID>874690</PMID>
  </reference>
  <reference>
    <citation>Rotimi VO, Duerden BI. The development of the bacterial flora in normal neonates. J Med Microbiol. 1981 Feb;14(1):51-62.</citation>
    <PMID>7463467</PMID>
  </reference>
  <reference>
    <citation>Orrhage K, Nord CE. Factors controlling the bacterial colonization of the intestine in breastfed infants. Acta Paediatr Suppl. 1999 Aug;88(430):47-57. Review.</citation>
    <PMID>10569223</PMID>
  </reference>
  <reference>
    <citation>Benno Y, Sawada K, Mitsuoka T. The intestinal microflora of infants: composition of fecal flora in breast-fed and bottle-fed infants. Microbiol Immunol. 1984;28(9):975-86.</citation>
    <PMID>6513816</PMID>
  </reference>
  <reference>
    <citation>Lundequist B, Nord CE, Winberg J. The composition of the faecal microflora in breastfed and bottle fed infants from birth to eight weeks. Acta Paediatr Scand. 1985 Jan;74(1):45-51.</citation>
    <PMID>3984727</PMID>
  </reference>
  <reference>
    <citation>Howie PW. Protective effect of breastfeeding against infection in the first and second six months of life. Adv Exp Med Biol. 2002;503:141-7. Review.</citation>
    <PMID>12026013</PMID>
  </reference>
  <reference>
    <citation>Heine W, Mohr C, Wutzke KD. Host-microflora correlations in infant nutrition. Prog Food Nutr Sci. 1992;16(2):181-97. Review.</citation>
    <PMID>1496120</PMID>
  </reference>
  <reference>
    <citation>Kunz C, Rodriguez-Palmero M, Koletzko B, Jensen R. Nutritional and biochemical properties of human milk, Part I: General aspects, proteins, and carbohydrates. Clin Perinatol. 1999 Jun;26(2):307-33. Review.</citation>
    <PMID>10394490</PMID>
  </reference>
  <reference>
    <citation>Kunz C, Rudloff S, Baier W, Klein N, Strobel S. Oligosaccharides in human milk: structural, functional, and metabolic aspects. Annu Rev Nutr. 2000;20:699-722. Review.</citation>
    <PMID>10940350</PMID>
  </reference>
  <reference>
    <citation>Engfer MB, Stahl B, Finke B, Sawatzki G, Daniel H. Human milk oligosaccharides are resistant to enzymatic hydrolysis in the upper gastrointestinal tract. Am J Clin Nutr. 2000 Jun;71(6):1589-96.</citation>
    <PMID>10837303</PMID>
  </reference>
  <reference>
    <citation>Erney RM, Malone WT, Skelding MB, Marcon AA, Kleman-Leyer KM, O'Ryan ML, Ruiz-Palacios G, Hilty MD, Pickering LK, Prieto PA. Variability of human milk neutral oligosaccharides in a diverse population. J Pediatr Gastroenterol Nutr. 2000 Feb;30(2):181-92.</citation>
    <PMID>10697138</PMID>
  </reference>
  <reference>
    <citation>Giovannini M, Riva E, Banderali G, Scaglioni S, Veehof SH, Sala M, Radaelli G, Agostoni C. Feeding practices of infants through the first year of life in Italy. Acta Paediatr. 2004 Apr;93(4):492-7.</citation>
    <PMID>15188977</PMID>
  </reference>
  <reference>
    <citation>Howie PW, Forsyth JS, Ogston SA, Clark A, Florey CD. Protective effect of breast feeding against infection. BMJ. 1990 Jan 6;300(6716):11-6.</citation>
    <PMID>2105113</PMID>
  </reference>
  <reference>
    <citation>Kramer MS, Kakuma R. Optimal duration of exclusive breastfeeding. Cochrane Database Syst Rev. 2002;(1):CD003517. Review. Update in: Cochrane Database Syst Rev. 2012;8:CD003517.</citation>
    <PMID>11869667</PMID>
  </reference>
  <verification_date>March 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 12, 2007</study_first_submitted>
  <study_first_submitted_qc>June 12, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 13, 2007</study_first_posted>
  <last_update_submitted>March 17, 2015</last_update_submitted>
  <last_update_submitted_qc>March 17, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 18, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Formula</keyword>
  <keyword>Feeding</keyword>
  <keyword>Healthy</keyword>
  <keyword>Full</keyword>
  <keyword>Term</keyword>
  <keyword>Infants</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

